Trial Profile
Effects of erdosteine on exercise-induced oxidative stress in patients with severe COPD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Erdosteine (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.